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Abstract
Background: Improved understanding of the interactions between bone cells and endothelial cells
involved in osteogenesis should aid the development of new strategies for bone tissue engineering.
The aim of the present study was to determine whether direct communication between bone
marrow stromal cells (MSC) and human umbilical vein endothelial cells (EC) could influence the
osteogenic potential of MSC in osteogenic factor-free medium.
Methods: After adding EC to MSC in a direct-contact system, cell viability and morphology were
investigated with the WST assay and immnostaining. The effects on osteogenic differentiation of
adding EC to MSC was systematically tested by the using Superarray assay and results were
confirmed with real-time PCR.
Results: Five days after the addition of EC to MSC in a ratio of 1:5 (EC/MSC) significant increases
in cell proliferation and cellular bridges between the two cell types were detected, as well as
increased mRNA expression of alkaline phosphatase (ALP). This effect was greater than that seen
with addition of osteogenic factors such as dexamethasone, ascorbic acid and -glycerophosphate
to the culture medium. The expression of transcription factor Runx2 was enhanced in MSC
incubated with osteogenic stimulatory medium, but was not influenced by induction with EC. The
expression of Collagen type I was not influenced by EC but the cells grown in the osteogenic factor-
free medium exhibited higher expression than those cultured with osteogenic stimulatory medium.
Conclusion: These results show that co-culturing of EC and MSC for 5 days influences osteogenic
differentiation of MSC, an effect that might be independent of Runx2, and enhances the production
of ALP by MSC.
Introduction
The goal of bone tissue engineering is the generation of
new bone from osteogenic cells, supported with biocom-
patible, biodegradable three-dimensional scaffolds [1,2].
The type of osteogenic cell most appropriate for bone tis-
sue engineering has yet to be determined. Bone marrow
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stromal cells (MSC) were first isolated by Friedenstein &
Owen [3,4] and are regarded as the main source of bone
progenitor cells in skeletal tissues. As MSC can be isolated
from adult bone marrow and expanded in vitro without
loss of differentiation potential, they are suitable candi-
dates for bone tissue engineering [1,5-7].
Bone is a highly vascularised tissue and close communica-
tion between blood vessels and bone cells is essential for
maintaining skeletal health [8,9]. Osteogenesis is a com-
plicated process influenced by physiological conditions,
cell-to-cell interactions, extracellular matrix formation
and surrounding vascularization. After a tissue-engi-
neered bone construct is implanted in vivo, induction of
initial vascularization is important [2]: in particular, the
survival of osteogenic cells at the center of scaffolds is
often threatened by the limited extent of initial vasculari-
zation [10]. Thus in bone tissue engineering, the addition
of vascular cells might offer several advantages over the
use of osteogenic cells alone [11].
Studies of the interaction between osteoblasts and
endothelial cells (EC) have demonstrated the formation
of microvessel-like structures and gap junction communi-
cations [12,13]. Paracrine factors such as vascular
endothelial growth factor (VEGF) are implicated as medi-
ators in these interactions [11,14]. EC derived from micro-
vasculature, umbilical veins or large blood vessels have
been used for generation of capillary-like structures and
vessels in vitro [15,16].
The relationship between bone cells and EC in osteogene-
sis has yet to be fully elucidated. Therefore, the aim of the
present study was to determine whether direct communi-
cation between the two cell types in an osteogenic factor-
free medium could influence osteogenic differentiation of
MSC.
Materials and methods
Cell culture and maintenance
Primary human MSC (StemCell Technologies, Vancouver,
BC, Canada) were cultured in MesenCult® complete
medium (StemCell Technologies) following the manufac-
turer's instructions. Purity of the cells was confirmed by
flow cytometry, which showed that > 90% of the cells
expressed CD29, CD44, CD105, CD166 and < 1%
expressed CD14, CD34 and CD45. The cells were
expanded in culture for use in the experiments with an
osteogenic stimulatory medium (StemCell Technologies)
that was freshly made and supplemented with dexameth-
asone, ascorbic acid and -glycerophosphate according to
the manufacturer's instructions.
Primary human umbilical vein endothelial cells were
obtained from Lonza (Clonetics®, Walkersville, MD). In
accordance with the manufacturer's instructions, the cells
were expanded in EGM Medium (Clonetics® EGM®) con-
taining 500 ml of Endothelial Cell Basal Medium and the
following growth supplements: BBE, 2 ml; hEGF, 0.5 ml;
Hydrocortisone, 0.5 ml; FBS, 10 ml; GA-1000, 0.5 ml.
Direct contact co-culture of EC and MSC
EC and MSC were trypsinized separately and then co-cul-
tured in 6-well plates (Nunclon, Roskilde, Denmark) and
plated at a ratio of 1:5. The cell density was 2 × 103/cm2
EC and 1 × 104/cm2 MSC in a mixed, osteogenic factor-
free medium. MSC were also grown alone in both osteo-
genic and osteogenic factor-free medium. The culture
medium was changed after 3 days.
Immunostaining
After 1, 3 and 5 days of culture, cells grown on Ø 18 mm
coverslips (VWR international, West Chester, PA) were
rinsed in phosphate buffered saline (PBS) and fixed with
4% paraformaldehyde for 10 min at room temperature. In
order to distinguish the two cell types, MSC were labelled
with FITC-CD90 (BD Pharmingen™, San Jose, CA) and EC
with TRITC-UEA I lectin (Vector Laboratories, Burlin-
game, CA). In brief, TRITC-UEA I lectin (1:500) was first
added and incubated for 1 h at room temperature. After
washing with PBS, CD 90 antibody was added and incu-
bated for 1 h at room temperature. The nuclei were
stained with DAPI (Molecular Probe™, UK) solution (1
g/ml) and washed with PBS. The samples were mounted
and examined by fluorescence microscopy (Nikon 80i,
Tokyo, Japan).
SEM
The cells were grown on coverslips for 1 and 5 days, and
then prepared for scanning electronic microscopy. The
samples were rinsed in 2.5% glutaraldehyde in -MEM
without serum and fixed for 30 min at room temperature.
The samples were then fixed in 2.5% glutaraldehyde in 0.1
M Na-cacodylate PH 7.2 with 0.1 M sucrose for further 30
min at room temperature. The samples were treated with
1% osmium tetroxide in distilled water for 1 h, followed
by dehydration through a graded series of ethanol from
70%, 80%, 95% and 100%. Critical point drying was car-
ried out using CO2 as transitional fluid. The samples were
mounted on aluminum holders and coated with a 10 nm
conducting layer of gold platinum. The samples were
examined in the scanning electronic microscope (Jeol JSM
7400F, Tokyo, Japan) using a voltage of 10 kV.
Cell viability and proliferation test
Cell proliferation and cell viability was analyzed using a
colorimetric assay for quantification of cleavage of the
tetrazolium salt WST-1 (Roche Molecular Biochemicals,
Hannheim, Germany) by mitochondrial dehydrogenases
in viable cells. The dye formed can be quantified by spec-
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trophotometer and is directly correlated to the number of
metabolically active cells in the culture. The cells were
grown in 96-well plates (Nunclon, Roskilde, Denmark)
for 1, 3 and 5 days. After each incubation period, the cells
were incubated for a further 12 h at 37°C with 100 l
medium containing 10 l WST-1 reagent. The samples
were shaken for 1 min and absorbance at 450 nm was
measured by a microplate spectrophotometer (BMG
LABTECH, GmbH, Germany). Fresh medium was used as
a negative control.
Total RNA extraction
Total RNA was isolated from 5-day-old cultures using Tri-
zol® reagent (Gibco BRL, Carlsbad, CA) combined with
E.Z.N.A.™ Tissue RNA isolation kit (Omega Bio-Tek, Nor-
cross, GA) according to the manufacturer's protocol. Total
RNA was quantified using a Nanodrop Spectrophotome-
ter (ThermoScientific NanoDrop Technologies, Wilming-
ton, DE). The quality of the RNA preparation was verified
by 1% agarose gel electrophoresis.
RT2 Profiler PCR Array of osteogenesis
Contamination of genomic DNA was removed from total
RNA samples by DNase I digestion prior to first-strand
synthesis. cDNA synthesis was performed with the RT2
PCR array First Strand Kit (SuperArray Bioscience Corpo-
ration, Frederick, MD). Human Osteogenesis RT2 Profiler
PCR Array and RT2 Real-time SyBR Green/ROX PCR Mix
were purchased from SuperArray Bioscience Corporation.
PCR was performed on ABI StepOne system (Applied Bio-
systems). The Ct method was used for data analysis,
and each gene fold-changes was calculated as difference in
gene expression between co-cultured MSC and MSC cul-
tured alone.
Real time Polymerase chain reaction (PCR)
The reverse transcription reaction was performed accord-
ing to the manufacturer's instructions using the High
Capacity cDNA Archive Kit (Applied Biosystems). From
300 ng to 1 g total RNA was obtained and mixed with
reverse transcriptase (RT) buffer, random primers and
Multiscribe RT. Mixtures of fresh RNA samples were seri-
ally diluted and used as standards to build up the standard
curve.
Real time qPCR was used to detect mRNA levels of glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH), alkaline
phosphatase (ALP), Collagen Type I (Col I) and Runt-
related transcription factor 2 (Runx2).
Quantitative RT-PCR (qRT-PCR) was performed under
standard enzyme and cycling conditions on a StepOne
system using four TaqMan gene expression assays:
Hs01029142_m1 (ALP), Hs00164099_m1 (Col I),
Hs00231692_m1 (Runx2), and TaqMan Pre-Developed
Assay GAPDH (4333764T). cDNA corresponding to 6 ng
of mRNA was used in each PCR reaction. Amplification
was carried out in 96-well thermal cycle plates on a Ste-
pOne system (Applied Biosystems). The Data were ana-
lyzed by StepOne software using the Relative Standard
Curve method. GAPDH was used as an endogenous con-
trol.
Statistical analysis
All the experiments were repeated three times using 3
donors to provide MSC and a pooled human EC. The data
were expressed as mean ± SD for n = 3. The data were
tested for normal distribution and variance homogeneity,
using one-way ANOVA. Differences between means were
considered statistically significant when p < 0.05. For sta-
tistical analysis, SPSS 15.0 software was used.
Results
Immunostaining
MSC were labelled with CD90 (green) and EC with UEA
1. All the nuclei were labelled with DAPI (Blue). MSC
were osteoblast-like in shape and in general the EC had
retained their cobblestone-like morphology. During 5
days' incubation, there was no obvious change in shape of
MSC. It could be observed that the number of MSC grad-
ually increased within 5 days (Fig. 1). Higher magnifica-
tion disclosed cellular bridges between the two cell types
after 1 day (Fig. 2d).
SEM
After 5 days, MSC showed larger spatial spreading and
extracellular matrix formation and EC were surrounded
by more cell foci (Figs. 2a and 2b). Under co-culture con-
ditions, the cells were attached and spread on the culture
plate (Fig. 2b). The phenomenon of cellular bridges
between MSC and EC disclosed by immunofluorescent
staining was also detected by SEM imaging after 1 day
(Figs. 2c and 2d).
Cell proliferation
In general, the results indicated that cell numbers
increased during the incubation period (Fig. 3). There was
no statistical difference between the two groups after day
1. After 3 and 5 days of incubation, the mitochondrial
activity of cells under co-culture conditions was signifi-
cantly higher compared to the control group.
RT2 Profiler PCR Array of osteogenesis
Samples were screened for the expression of 84 genes
linked to osteoblast differentiation and bone metabolism.
The data reflected that MSC had a pattern of constitutive
expression for the majority of osteogenic genes (Fig. 4 and
5a). In total, 25 genes of MSC showed either up- or down-
regulated expression after treatment with endothelial cells
for 5 days (Fig. 4). Of these, 5 genes were statistically sig-
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nificantly different (Fig. 5b). After co-culturing with EC
for 5 days, MSC had a 4.92-fold up-regulation of ALP. The
expressions of RunX2 and Col I were down-regulated, but
the differences were not significant (P > 0.05). At this time
point, the detected level of bone gamma-carboxygluta-
mate protein (BGLAP) was lower (Ct > 33). The following
genes related to chondrocyte differentiation were down-
regulted: SRY-box containing gene 9 (Sox 9), 6.43-fold;
Matrix metallopeptidase 2 (MMP2), 6.9-fold; Epidermal
growth factor (EGF), 5.63-fold; Fibroblast growth factors
2 (FGF2), 6.33-fold.
PCR results
In order to confirm the Superarray results, real-time PCR
was performed independently and 5 day osteogenic stim-
ulatory medium (OM)-induced MSC were used as a posi-
tive control (Fig. 6).
ALP and Col I expression were used as early markers of
osteogenic differentiation. After 5 days, there was a statis-
tically significant (P < 0.01) increase of ALP mRNA levels
in MSC/EC co-cultures compared with MSC alone. The
addition of osteogenic stimulatory medium to MSC also
resulted in increased ALP expression, but interestingly this
increase was significantly less than the expression of ALP
by MSC co-cultured with EC. There was almost no detect-
able expression of ALP in monocultures of EC.
Adding osteogenic stimulatory medium significantly
decreased Col I expression compared with MSC with or
without EC (P < 0.05). The addition of EC to MSC caused
no significant difference in expression of Col I.
The mRNA expression of Runx2 increased significantly
after addition of osteogenic stimulatory medium com-
pared with expression by MSC alone or with EC (P <
0.05). Addition of EC to MSC caused no significant differ-
ence in expression of Runx2.
Discussion
The present in vitro study tested the hypothesis that direct
communication with endothelial cells might enhance the
osteogenic potential of MSC. Under osteogenic inductive
medium culture conditions, MSC progress from imma-
ture progenitor cells through the osteoblastic lineage to
become osteocytes [17,18]. Medium supplements such as
dexamethasone (DEX), ascorbic acid and -glycerolphos-
phate have been shown to influence the development of
MSC into more highly differentiated phenotypes. How-
ever, the underlying mechanism has not been clarified.
Differentiation of stem cells towards osteogenesis requires
interaction with other cells at a crucial moment [3]. In
most of the co-culture studies to date, cells have been
treated with osteogenic stimulatory medium [14,19,20],
whereas the present study was undertaken without the
addition of osteogenic supplements to MSC or to the co-
culture group.
In the co-culture studies cited above [14,19,20], either
conditioned medium was used or the two cell types were
separated by a permeable membrane inserted into the cul-
ture plate. The use of inserts in the non-contact culture
systems facilitates analysis and eliminates the risk of con-
tamination between the two cell types. Soluble factors
secreted by one cell type can move through the inserts to
induce cell differentiation. The major disadvantage of
using membranes or conditioned medium is that they
prevent intimate physical contact or regulatory communi-
cation between the cell types. This limitation of signal
transduction is in contrast to conditions in vivo [11]. For
Cells grown on the coverslips for 1 (a), 3 (b) and 5 (c) days: MSC were labeled with CD90 (g een), EC with UEA-1 (red) and nuclei with DAPI (blue)Figure 1
Cells grown on the coverslips for 1 (a), 3 (b) and 5 (c) 
days: MSC were labeled with CD90 (green), EC with 
UEA I (red) and nuclei with DAPI (blue).
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these reasons, the direct contact culture system was
adopted in the present study. To reduce the influence of a
mixture of cells on gene analysis, the present studies were
designed using a 1:5 (EC:MSC) cell mix for 5 days of cul-
ture. Different EC:MSC ratios were co-cultured in pilot
studies (data was not showed) and it was found that EC
could grow well and exist as a continus stimulatory factor
for MSC in the 1:5 ratio which was closely mimics the in
vivo situation [11].
The SEM and immunostaining results indicated that there
might be communication between the two cell types after
5 days of culture. The design of the present study did not
include specific tracing of such communication and the
specific signal transduction pathways between two cell
types could therefore not be defined. In a previous study,
microscopic examination disclosed the presence of tun-
neling nanotubes (TNT), which might participate in cell-
to-cell communication between the two cell types [21].
The communication suggested by the present study might
be attributable to the formation of TNT structures, but fur-
ther investigation is required for confirmation.
The WST-1 assay proliferation results which allow quanti-
fication of mitochondrial metabolism showed that addi-
tion of EC did not inhibit cellular growth of MSC after 3
and 5 days of co-culture. Similar results have also been
Morphology of cell communications between co-cultured MSC and EC: SEM showing morphology of EC after 5 days (a); SEM sh wing MSC and EC after 5 days (b); cellular bridge between MSC and EC disclosed by SEM (c) and by immunostaining (d)Figure 2
Morphology of cell communications between co-cultured MSC and EC: SEM showing morphology of EC after 
5 days (a); SEM showing MSC and EC after 5 days (b); cellular bridge between MSC and EC disclosed by SEM 
(c) and by immunostaining (d).
Results obtained by WST-1 assay to describe cell viability and proliferation after 1, 3 and 5 daysFig re 3
Results obtained by WST-1 assay to describe cell via-
bility and proliferation after 1, 3 and 5 days. The data 
were representative for all donors and presented as mean ± 
standard deviations. * P < 0.05 (compared with MSC group).
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reported from previous studies using different co-culture
methods and ratios [14,19,20]. Bone modelling is initi-
ated by osteoblastic differentiation of mesenchymal cells
into preosteoblasts which then differentiate into func-
tional osteoblasts producing bone matrix proteins [22].
Collagen type I is one of the major extracellular matrix
proteins in fibrous tissue and bone [23]. In the present
study, the PCR results showed no significant change in
Col I expression after addition of EC to MSC.
ALP is commonly expressed in bone, liver, kidney, brain,
lung and neutrophils [24]. Although ALP isolated from
bone tissue is considered to have a major role in skeletal
mineralization, the specific biologic functions of the bone
isoforms are currently unknown. Importantly, in the early
stages of osteoblast-mediated mineralization, bone ALP is
considered to have an important function in the removal
of inorganic pyrophosphate, a potent inhibitor of miner-
alization [24]. ALP is often used as a biochemical and his-
tochemical marker for identification and evaluation of
osteogenesis. Interestingly in the present study, there was
nearly a 5-fold increase in ALP expression when MSC were
co-cultured with EC of less than 20% of the total cell pop-
ulation. This increase was demonstrated by culturing the
cells in osteogenic factor-free medium using both Super-
array and PCR methods. Furthermore, the PCR results
showed that after 5 days of culturing MSC and EC, the
effect induced by EC was greater than that the effect
induced by osteogenic stimulatory medium.
During osteogenesis from mesenchymal progenitors, var-
ious extrinsic factors such as dexamethasone and
cytokines regulate osteoblastic differentiation. Two major
pathways for osteogenesis are recognized; one is Runx2
RT2 Profiler PCR Array of osteogenesis after 5 daysFigure 4
RT2 Profiler PCR Array of osteogenesis after 5 days. Overview of scatter plot on expression of 84 osteogenesis genes: 
red dot is up-regulated gene and green dot is down-regulated genes.
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dependent and the other is Runx2 independent [25]. To
investigate the possible reasons underlying the changes in
ALP expression described above, the key transcription fac-
tor Runx2 was tested by PCR. Within 5 days of induction,
the addition of osteogenic stimulatory medium to MSC
significantly induced the expression of Runx2. However,
co-culturing of MSC with EC did not influence Runx2
expression. Runx2/cbfa1 was used as an early-stage tran-
scription factor for osteoblast differentiation. In Runx2/
cbfa1 null mice, osteoblast differentiation is arrested in
both the endochondral and intramembranous skeleton
[26,27]. It has been shown that Runx2 plays a role in the
commitment-step to osteo-chondro progenitor cells [28].
A previous in vitro study has shown that dexamethasone
and Runx2 could synergistically induce osteoblastic differ-
entiation [29]. The main component of the osteogenic
stimulatory medium was dexamethasone and the results
demonstrated that Runx2 played a crucial role during dex-
amethasone-induced osteoblastic differentiation.
The findings of the present study indicate that up-regula-
tion ALP from MSC was induced by EC and might be inde-
pendent of Runx2 but the identification of other potential
pathways will require further investigation. However,
with the low level of bone gamma-carboxyglutamate pro-
tein (BGLAP) expressed by MSC, it is unlikely that these
immature cells had the potential to undergo terminal dif-
ferentiation within 5 days of co-culture with EC. There-
fore, our results suggest that in 5 days' induction, EC
could direct MSC to the early stage of osteogenic cells.
Since mesenchymal stem cell could differentiate into
chondrocytes through along a multistep, recruitment of
chondrogenitor cells are related with the communication
of neighboring cells as EC [30]. It is known that SRY-box
containing gene 9 (Sox 9) is a transcription factor that is
completely required for chondrocyte differentiation asso-
ciated with fibroblast growth factors (FGFs) [30,31].
MMP2 has wide substrate specificity for cartilage matrix
constituents [32]. The Superarray disclosed that the genes
RT2 Profiler PCR Array of osteogenesis after 5 daysFigure 5
RT2 Profiler PCR Array of osteogenesis after 5 days. (a): Histogram showing the mean cycle threshold distribution for 
MSC group at 5 days. Low CT values (< 25) represent genes at high transcript copy number. CT values of greater than 35 were 
considered to be outside the detection threshold of the system. (b): Fold changes of genes by co-culturing group compared 
with MSC group. MSC group was used as reference group and set as 1. Results were reported as fold changes ± fold-difference 
(2-Ct ± 2-(Ct ± SD)). * P < 0.05.
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related to chondrocyte differentiation (Sox 9, MMP2,
FGF2) were down-regulated, suggesting that EC might
provide important signals for chondrocytic differentiation
and have an important influence on chondrocyte commit-
ment and maturation.
Further investigation is warranted to determine the effect
on the differentiation potential of MSC of varying the
ratio of EC to MSC and also to clarify the role of EC in the
regulation of MSC differentiation into osteoblasts during
long-term incubation.
Conclusion
Under osteogenic factor-free conditions, the addition of
EC induced the expression of ALP by MSC in a short incu-
bation time (5 days). The ALP expression was even higher
than that resulting from the addition of osteogenic stimu-
latory medium to MSC. Based on these preliminary results
it is concluded that co-culturing MSC with EC influenced
osteogenic differentiation of MSC and this effect might be
independent of Runx2. Future studies will be directed
towards the induction of ALP and the regulatory role of
EC in the differentiation of MSC into osteoblasts.
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